ICD-10 Code D36.0: Benign neoplasm of lymph nodes

Key Takeaways

ICD-10 Code D36.0 (Benign neoplasm of lymph nodes) is a billable, specific ICD-10-CM code valid for FY2026 (October 1, 2025 through September 30, 2026).

D36.0 requires a confirmed pathology report diagnosing a benign neoplasm before assignment; negative lymph nodes or lymphadenopathy alone do not support this code.

D36.0 is frequently confused with R59 (enlarged lymph nodes/lymphadenopathy) – the key distinction is histological confirmation of a true neoplastic process versus reactive enlargement.

Pabau’s claims management software supports accurate ICD-10-CM coding workflows, helping practices reduce claim errors and missing documentation associated with benign neoplasm codes.

ICD-10 Code D36.0 is the billable ICD-10-CM code for a benign neoplasm of lymph nodes, valid for FY2026. It applies only after a pathology report confirms a benign neoplastic process – not enlarged or reactive nodes, which fall under R59.

This reference guide covers ICD-10 Code D36.0 – its clinical definition, billable status, sequencing rules, documentation requirements, related codes, and how it maps to common excision procedures in surgical billing workflows.

ICD-10 Code D36.0: Clinical description

ICD-10 Code D36.0 identifies a benign neoplasm of lymph nodes. It sits within Chapter 2 of the ICD-10-CM classification (Neoplasms, C00-D49), under the block D10-D36 (Benign neoplasms, except benign neuroendocrine tumors), as maintained by the World Health Organization’s ICD-10 browser.

Lymph nodes are small, bean-shaped organs distributed throughout the body as part of the lymphatic system. They filter lymph fluid and house immune cells. A benign neoplasm of the lymph nodes refers to an abnormal, non-cancerous proliferation of tissue within or immediately adjacent to a lymph node – distinct from both reactive enlargement and malignant transformation.

Common histological findings that support D36.0 include lymphangioma (a benign tumor of lymphatic vessels), lipoma within lymph node capsules, and certain fibrous or vascular growths. The code does not cover lymphadenopathy, enlarged lymph nodes with unclear etiology, or reactive hyperplasia – those fall under R59 and related codes.

Anatomical scope of D36.0

D36.0 applies to benign neoplasms occurring in lymph nodes across all anatomical regions – cervical, axillary, inguinal, mediastinal, and retroperitoneal. The code does not specify location. When location specificity is clinically relevant for documentation or surgical planning, coders should capture site detail in the operative and pathology reports even though ICD-10-CM does not subdivide D36.0 by region.

Pabau’s claims management software helps clinical teams attach accurate ICD-10-CM codes to encounters at the point of documentation. This reduces the risk that a confirmed benign pathology result gets coded under a less-specific or incorrect diagnosis code at submission.

For practices managing oncology-adjacent coding, this workflow integration matters for audit readiness. The same precision applies to other benign neoplasm codes – compare how ICD-10 Code D35.7 (benign neoplasm of endocrine glands) also requires precise category selection to avoid crossover errors.

D36.0 and related codes in the D36 family

D36.0 belongs to the parent category D36 (Benign neoplasm of other and unspecified sites). Understanding the full D36 family helps coders avoid defaulting to the unspecified code when a more precise option exists.

Practices that code connective and soft tissue neoplasms (C49.6) alongside lymph node pathology will recognize the importance of code specificity across neoplasm categories. Defaulting to D36.9 when D36.0 is clearly supported by pathology results in a less-defensible claim submission and risks downcoding queries from payers.

Billable status and ICD-10 Code D36.0 coding guidelines

D36.0 is a billable, specific ICD-10-CM code. According to the CDC/NCHS ICD-10-CM tool, D36.0 is valid for the submission of HIPAA-covered transactions from October 1, 2025 through September 30, 2026 (FY2026). Coders can use it as a principal or secondary diagnosis on claims without needing a more specific sub-code.

Several coding rules govern its correct application.

Pathology dependency rule

D36.0 may only be assigned after a confirmed pathology report documents a benign neoplasm of lymph nodes. Coding from a surgeon’s pre-operative impression, a radiology report describing a “suspicious mass,” or a clinical note citing enlarged nodes alone is not sufficient. The AAPC coding guidance – consistent with ICD-10-CM Official Guidelines for Coding and Reporting – requires a definitive histological diagnosis before this code is valid.

Negative lymph nodes found incidentally during excision or sentinel node procedures do not support D36.0 assignment either. A negative result is not a diagnosis. Coders should document the primary surgical diagnosis and leave the lymph node result uncodified when pathology returns negative.

Good client record management practices mean the pathology result and the resulting ICD-10 assignment stay linked at the encounter level, making retrospective audits far cleaner. The same pathology-before-code logic governs other benign neoplasm entries, such as ICD-10 Code D10.6 (benign neoplasm of nasopharynx), where a confirmed histological finding is required before assignment.

Principal vs. secondary diagnosis sequencing

When the benign lymph node neoplasm is the primary reason for the encounter, D36.0 serves as the principal diagnosis. When a patient presents for treatment of a known malignancy and D36.0 reflects an incidental separate finding confirmed by pathology, it is sequenced as a secondary code behind the principal malignant diagnosis.

Coders should not sequence D36.0 ahead of an active malignant neoplasm code simply because the lymph node biopsy result was benign. Sequencing follows the reason for the encounter, not the most benign finding.

D36.0 vs. R59 and other related ICD-10 codes

The most common coding error with D36.0 is using it interchangeably with R59 (Enlarged lymph nodes). These codes describe fundamentally different clinical situations, and payers will scrutinize claims where the supporting documentation does not match the diagnosis category.

The distinction matters clinically and financially. R59 codes sit in Chapter 18 (Symptoms and signs), which signals to payers that the diagnosis is still under investigation. D36.0 sits in Chapter 2 (Neoplasms), indicating a confirmed diagnosis. Submitting D36.0 on a claim backed only by a symptom-level note is a compliance risk that could trigger recoupment requests on audit.

Practices specializing in surgical oncology or complex soft-tissue cases benefit from using dermatology EMR software that flags coding category mismatches before claims go out the door. For reference, the same principle of separating symptom codes from confirmed-diagnosis codes applies when coding blood disorder manifestations (D77), where the distinction between definitive and uncertain findings drives sequencing decisions.

Reduce claim errors tied to ICD-10-CM coding mistakes

Pabau connects pathology documentation to billing workflows, so the right diagnosis code gets attached to the right encounter every time. See how it works for surgical and oncology-adjacent practices.

Book a demo

Documentation requirements for ICD-10 Code D36.0

Accurate documentation is the foundation of a defensible D36.0 claim. Payers and auditors expect the record to contain several specific elements before this diagnosis code is assigned.

• Pathology report: The single most critical document. Must include the histological diagnosis confirming a benign neoplasm, the specimen site, and the date of analysis.
• Operative note: Describes the procedure performed, the anatomical site, and the clinical indication. The surgeon’s pre-operative impression should be updated post-pathology if initial findings were uncertain.
• Physician attestation: The treating provider must document the final confirmed diagnosis in the encounter note. Pathology alone without a physician-authored diagnosis statement is insufficient for code assignment in many payer audits.
• Linkage between note and billing: The claim’s diagnosis code must trace back to a specific encounter note and corresponding pathology report. Orphaned codes with no supporting documentation are the primary target during RAC audits.

According to CMS ICD-10 coding guidelines, diagnosis codes are assigned to the highest level of specificity supported by the medical record. Using D36.0 when only reactive lymphadenopathy is documented – without a biopsy result – does not meet this standard and creates a denial risk at claim adjudication.

Managing these documentation chains is easier when clinical notes, pathology results, and billing codes are stored within the same HIPAA-compliant practice software environment. Practices that manage medical documentation workflows across paper-based and digital systems often find that pathology notes get separated from encounter records, creating exactly the kind of missing documentation that drives D36.0 audit findings.

CPT procedure codes commonly paired with D36.0

D36.0 most often appears as the supporting diagnosis code for lymph node excision procedures. The relevant CPT codes fall in the 38500-38530 range, covering superficial and deep lymph node biopsies and excisions. Pairing the correct CPT procedure code with D36.0 (when pathology supports the benign diagnosis) creates a coherent claim that payers can adjudicate without additional documentation requests.

Payer medical necessity policies for benign lymph node excision vary. Some payers require prior authorization when D36.0 is the primary diagnosis supporting an elective excision, particularly if the clinical notes do not document symptom burden (pain, size progression, functional impairment) alongside the pathology result.

Checking your payer’s or MAC’s active Local Coverage Determinations linked to D36.0 before submitting is a practical step for high-volume surgical billing teams. Aligning this check with sound healthcare revenue cycle management keeps benign neoplasm claims moving without avoidable denials.

Practices that bill a mix of surgical and diagnostic encounters benefit from practice management software features that support pairing procedure and diagnosis codes during charge capture, rather than relying on manual coder review at the end of the billing cycle.

Teams handling complex surgical documentation also use digital intake forms to capture pre-operative symptom history, which strengthens medical necessity documentation when payers request records for benign neoplasm excision claims.

Conclusion

The coding mistake most likely to cause problems with D36.0 is simple: assigning the code before pathology confirms it. Once that confirmation exists, the code is straightforward – billable, specific, and appropriately placed in the neoplasm chapter for a confirmed benign lymph node diagnosis.

Practices managing surgical oncology workflows, soft-tissue excisions, or incidental benign neoplasm findings benefit from documentation systems that keep pathology results, encounter notes, and diagnosis codes connected within a single workflow. Pabau’s plastic surgery EMR supports exactly this kind of documentation continuity, helping surgical teams move from confirmed pathology result to accurate claim submission without losing documentation integrity along the way. To see how Pabau handles coding workflows for oncology-adjacent surgical practices, book a demo.

Continue your research

Need the fundamentals of how diagnosis and procedure codes flow through a clean claim? What is medical billing walks through the full claim lifecycle, useful context for coders confirming benign neoplasm diagnoses before submission.

Want another confirmed-diagnosis coding walkthrough in the neoplasm and blood chapters? ICD-10 Code D45: Polycythemia vera shows how a confirmed hematologic diagnosis is documented and billed.

Want to see how Pabau supports surgical practice documentation workflows? Plastic surgery EMR details the clinical record management tools built for practices handling complex surgical coding and pathology-dependent diagnoses.

Frequently Asked Questions